Orthocell Ltd's (ASX:OCC) Paul Anderson speaks to Proactive following the news it's been granted patents for its CelGro® collagen rope in China and Hong Kong, bringing the number of countries it is patented in to five. The collagen rope product, part of the company’s CelGro® collagen scaffold platform technology, is designed to augment ligament repair surgeries such as anterior cruciate ligament (ACL) reconstruction.
Orthocell welcomes further Asian patent protection for CelGro collagen rope
